• Recruitment Status:
    number of women enrolled in IMPROvED to date

  • Pre-eclampsia screening of
    5000 European women in 5 countries

  • Novel metabolomics and proteomics biomarkers
    to detect pre-eclampsia and improve pregnancy outcomes

  • An effective screening test has the potential for
    significant health and economic impact

News

2018-05-22

World Preeclampsia Day 2018

Today, organisations around the world join forces to raise awareness on preeclampsia. On May 22, 2017, the World Preeclampsia Day took place for the very first time and today, the world shall again pay particular attention to preeclampsia, a disorder that claims the lives of more that 76,000 women and over 500,000 infants worldwide every year. Ending Eclampsia published a great infographic that that can be downloaded from their website.

2018-05-20

Press Release May 2018

The EU-funded project IMPROvED established a unique collaborative framework between innovative SMEs and a network of European clinicians and Researchers to enable the development of a clinically robust predictive blood test for pre-eclampsia in first time pregnant women. Download our latest press release here.

2018-05-15

Congratulations to our Partner Metabolomic Diagnostics for securing new EU Funding

We congratulate Metabolomic Diagnostics for securing €2 million in EU funding under the Horizon 2020 SME Instrument. Their project "Improving Pregnancy Outcomes Globally - IPOG" has been selected from almost 1300 applicants and the Cork-based biotech company will use the award to commercialise its breakthrough product, PrePsia™. Find out more about these exciting news and product here.